>Mercado de diagnóstico de AVC Ásia-Pacífico, por gravidade (moderada, grave, ligeira), tipo (tomografia computorizada (tomografia computorizada), angiografia por tomografia computorizada (CTA), imagem por ressonância magnética (RM), angiografia por ressonância magnética (RM ), ecografia Doppler transcraniana , Teste de impulso cefálico por vídeo (VHIT), Outros), Aplicação (AVC isquémico, AVC hemorrágico, Ataques isquémicos transitórios (TIAS)), Utilizador final (Hospitais, Clínicas, Centros de cirurgia ambulatória, Assistência domiciliária), Canal de distribuição (Concurso direto, Terceiros Distribuidores terceiros, outros), estágio (pré-operatório, peri-operatório, pós-operatório), país (Japão, China, Índia, Coreia do Sul, Austrália, Singapura, Tailândia, Malásia, Indonésia, Filipinas e resto da Ásia-Pacífico) Tendências da indústria e Previsão para 2028
Análise de Mercado e Insights: Mercado de Diagnóstico de AVC Ásia-Pacífico
Espera-se que o mercado de diagnóstico de AVC da Ásia-Pacífico ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 11,2% no período de previsão de 2021 a 2028 e deverá atingir os 6.969,06 milhões de dólares até 2028. O aumento das doenças crónicas e do cancro são os principais impulsionadores que deverão impulsionar a procura do mercado no período de previsão.
Um acidente vascular cerebral ocorre quando o fornecimento de sangue ao cérebro diminui ou é completamente bloqueado, o que impede o tecido cerebral de obter oxigénio e nutrientes. Existem vários tipos de dispositivos de diagnóstico utilizados para detetar o acidente vascular cerebral e os seus sintomas iniciais, por exemplo, tomografia computorizada (TC SCAN), angiografia por tomografia computorizada (CTA), ressonância magnética (RM), angiografia por ressonância magnética (RM ), transcraniana Ecografia Doppler e outros.
A crescente incidência de AVC e de doenças cardiovasculares e neurológicas aumentou a procura de diagnósticos de AVC nos países em desenvolvimento. Além disso, o aumento das despesas com cuidados de saúde está a impulsionar o crescimento do mercado. Por outro lado, o elevado custo do diagnóstico pode dificultar o crescimento do mercado. A presença de players de mercado e o lançamento de novos produtos constituem uma oportunidade. No entanto, a falta de profissionais qualificados pode desafiar o mercado.
O relatório de mercado de diagnóstico de AVC fornece detalhes de quota de mercado, novos desenvolvimentos, o impacto dos participantes do mercado nacionais e localizados, análise de oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações de mercado, aprovações de produtos , decisões estratégicas, lançamentos de produtos, expansões geográficas, e inovações tecnológicas do mercado. Para compreender a análise e o cenário do mercado, contacte-nos para obter um Analyst Brief. A nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir a meta desejada.
Âmbito e dimensão do mercado de diagnóstico de AVC da Ásia-Pacífico
O mercado de diagnóstico de AVC da Ásia-Pacífico está categorizado em seis segmentos notáveis que se baseiam na gravidade, tipo, aplicação, utilizadores finais, canal de distribuição e fase.
- Com base na gravidade, o mercado de diagnóstico de AVC da Ásia-Pacífico está segmentado em moderado, grave e ligeiro. Em 2021, prevê-se que o segmento moderado domine o mercado devido ao aumento da população de doentes com AVC.
- Com base no tipo, o mercado de diagnóstico de AVC da Ásia-Pacífico está segmentado em tomografia computadorizada (tomografia computadorizada), angiografia por tomografia computadorizada (CTA), ressonância magnética (MRI), angiografia por ressonância magnética (MRA), ultrassom Doppler transcraniano , cabeça de vídeo teste de impulso (VHIT) e outros. Em 2021, prevê-se que o segmento da tomografia computorizada (TC) domine o mercado devido ao aumento das doenças cardiovasculares.
- Com base na aplicação, o mercado de diagnóstico de AVC da Ásia-Pacífico está segmentado em AVC isquémico, AVC hemorrágico e ataques isquémicos transitórios (TIAS. Em 2021, espera-se que o AVC isquémico domine o mercado com a crescente incidência de AVC isquémico globalmente.
- Com base nos utilizadores finais, o mercado de diagnóstico de AVC da Ásia-Pacífico está segmentado em hospitais, cuidados de saúde domiciliários, centros de cirurgia ambulatória e clínicas. Em 2021, prevê-se que o segmento hospitalar domine o mercado devido ao crescente número de doenças crónicas como as cardiovasculares e as neuro.
- Com base no canal de distribuição, o mercado de diagnóstico de AVC da Ásia-Pacífico está segmentado em licitação direta, distribuidor terceirizado, entre outros. Em 2021, prevê-se que o concurso direto domine o mercado devido aos crescentes avanços na tecnologia.
- Com base no estágio, o mercado de diagnóstico de AVC da Ásia-Pacífico está segmentado em pré-operatório, peri-operatório e pós-operatório. Em 2021, prevê-se que o pré-operatório domine o mercado devido à crescente incidência de AVC.
Análise ao nível do país do mercado de diagnóstico de AVC
O mercado de diagnóstico de AVC é analisado e são fornecidas informações sobre o tamanho do mercado com base na gravidade, tipo, aplicação, utilizadores finais, canal de distribuição e fase.
Os países abrangidos no relatório de mercado de diagnóstico de AVC são o Japão, China, Austrália, Índia, Coreia do Sul, Singapura, Indonésia, Tailândia, Malásia, Filipinas e o resto da Ásia-Pacífico.
Espera-se que o segmento de diagnóstico de AVC na região Ásia-Pacífico cresça com a maior taxa de crescimento no período de previsão de 2021 a 2028 devido ao número crescente de fabricantes de diagnóstico de AVC. O Japão está a liderar o crescimento do mercado de diagnóstico de AVC da Ásia-Pacífico, e espera-se que o segmento hospitalar domine o segmento de diagnóstico de AVC devido ao número crescente de incidentes de incêndio no país.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Increase in FDA Approval is Boosting the Market Growth of Stroke diagnostics
The stroke diagnostics market also provides you with detailed market analysis for every country's growth in the stroke diagnostics industry with stroke diagnostics drugs sales, the impact of advancement in the stroke diagnostics technology, and changes in regulatory scenarios with their support for the stroke diagnostics market. The data is available for the historic period 2011 to 2019.
Competitive Landscape and Stroke Diagnostics Market Share Analysis
Stroke diagnostics market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the stroke diagnostics market.
- The major companies which are dealing in the Asia-Pacific stroke diagnostics market are Siemens, Koninklijke Philips N.V., General Electric Company, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., FUJIFILM Holdings Corporation, Canon Inc., ALPINION MEDICAL SYSTEMS Co., Ltd, Analogic Corporation, Aspect Imaging Ltd, BPL Medical Technologies, Carestream Health, ESAOTE SPA, FUJIFILM Holdings Corporation, Hologic, Inc., IMRIS, Deerfield Imaging Inc., Medfield Diagnostics AB, MEDTRON AG, Neusoft Corporation, SAMSUNG, Shenzhen Anke High-Tech CO., Ltd., Shimadzu Corporation, SIUI, SternMed GmbH, Stryker, among others.
Many product launches and agreements are also initiated by companies worldwide, which are also accelerating the stroke diagnostics market.
For instances,
- In February 2021, Koninklijke Philips N.V announced that they had successfully completed the acquisition of BioTelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring. The acquisition has helped the company add new technological wearable sensing products to their product pipeline
- Em maio de 2021, a General Electric Company anunciou que tinha adquirido a Zionexa, uma empresa privada francesa que desenvolve e comercializa agentes de imagem que podem ajudar no diagnóstico dos médicos. Isto tem ajudado a empresa a aumentar os seus instrumentos de diagnóstico
A colaboração, o lançamento de produtos, a expansão do negócio, a atribuição de prémios e reconhecimento, as joint ventures e outras estratégias do player de mercado melhoram o mercado da empresa no mercado de diagnóstico de AVC, o que também beneficia a organização para melhorar a sua oferta de diagnóstico de AVC.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC STROKE DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
5 EPIDEMIOLOGY
6 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: REGULATIONS
6.1 REGULATION IN THE U.S.
6.2 REGULATION IN EUROPE
6.3 REGULATION IN CHINA
6.4 REGULATION IN JAPAN
6.5 REGULATION IN SOUTH AFRICA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 TECHNOLOGICAL ADVANCEMENT
7.1.2 INCREASE IN THE INCIDENCE OF STROKE
7.1.3 INCREASE IN THE GERIATRIC POPULATION
7.1.4 INCREASE IN NUMBER OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASES
7.2 RESTRAINTS
7.2.1 HIGH COST OF DIAGNOSIS
7.2.2 INCREASE IN PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE SPENDING
7.3.2 INCREASE IN DIABETIC POPULATION AND OBESITY
7.3.3 INCREASE IN FDA APPROVAL AND PRODUCT LAUNCH
7.3.4 RISE IN AWARENESS REGARDING HEALTH AND STROKE
7.4 CHALLENGES
7.4.1 UNFAVORABLE REIMBURSEMENT SCENARIO
7.4.2 COMPLICATION RELATED TO DIAGNOSTIC DEVICES
8 IMPACT OF COVID-19 ON ASIA PACIFIC STROKE DIAGNOSTICS MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC INITIATIVES
8.5 CONCLUSION
9 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY
9.1 OVERVIEW
9.2 MODERATE
9.3 SEVERE
9.4 MILD
10 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE
10.1 OVERVIEW
10.2 COMPUTED TOMOGRAPHY (CT SCAN)
10.3 COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA)
10.4 MAGNETIC RESONANCE IMAGING (MRI)
10.5 MAGNETIC RESONANCE ANGIOGRAPHY (MRA)
10.6 TRANSCRANIAL DOPPLER ULTRASOUND
10.7 VIDEO HEAD IMPULSE TEST (VHIT)
10.8 OTHERS
10.8.1 CAROTID ULTRASOUND
10.8.2 CAROTID ANGIOGRAPHY
10.8.3 ELECTROCARDIOGRAPHY (EKG)
10.8.4 ECHOCARDIOGRAPHY
10.8.5 BLOOD TESTS
10.8.6 NUCLEAR NEUROIMAGING
10.8.7 OTHERS
11 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ISCHEMIC STROKE
11.2.1 THROMBOTIC STROKES
11.2.2 EMBOLIC STROKES
11.3 HEMORRHAGIC STROKE
11.3.1 INTRACEREBRAL HEMORRHAGE
11.3.2 SUBARACHNOID HEMORRHAGE
11.4 TRANSIENT ISCHEMIC ATTACKS (TIAS)
12 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITAL
12.3 CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 HOME HEALTHCARE
12.6 OTHERS
13 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
14 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE
14.1 OVERVIEW
14.2 PRE OPERATIVE
14.3 PERI OPERATIVE
14.4 POST OPERATIVE
15 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY REGION
15.1 ASIA-PACIFIC
15.1.1 JAPAN
15.1.2 CHINA
15.1.3 INDIA
15.1.4 SOUTH KOREA
15.1.5 AUSTRALIA
15.1.6 SINGAPORE
15.1.7 THAILAND
15.1.8 MALAYSIA
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 REST OF ASIA-PACIFIC
16 STROKE DIAGNOSTICS MARKET COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 SIEMENS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 KONINKLIJKE PHILIPS N.V.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 GENERAL ELECTRIC COMPANY
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 CANON INC
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 ALPINION MEDICAL SYSTEMS CO., LTD
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 ANALOGIC CORPORATION
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ASPECT IMAGING LTD
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 BPL MEDICAL TECHNOLOGIES
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 CARESTREAM HEALTH
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.11 ESAOTE SPA
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENTS
18.12 FONAR CORP
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENT
18.13 FUJIFILM HOLDINGS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 HOLOGIC, INC
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENTS
18.15 IMRIS, DEERFIELD IMAGING INC.
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 MEDFIELD DIAGNOSTICS AB
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 MEDTRON AG
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 NEUSOFT CORPORATION
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 SAMSUNG
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.2 SHENXHEN ANKE HIGH-TECH CO., LTD.
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENT
18.21 SHIMADZU CORPORATION
18.21.1 COMPANY SNAPSHOT
18.21.2 REVENUE ANALYSIS
18.21.3 PRODUCT PORTFOLIO
18.21.4 RECENT DEVELOPMENTS
18.22 SIUI
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENTS
18.23 STERNMED GMBH
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 STRYKER
18.24.1 COMPANY SNAPSHOT
18.24.2 REVENUE ANALYSIS
18.24.3 PRODUCT PORTFOLIO
18.24.4 RECENT DEVELOPMENTS
18.25 TERASON DIVISION TERATECH CORPORATION
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
Lista de Tabela
TABLE 1 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 2 ASIA PACIFIC MODERATE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 ASIA PACIFIC SEVERE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 ASIA PACIFIC MILD IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC COMPUTED TOMOGRAPHY (CT SCAN) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY (MRA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC TRANSCRANIAL DOPPLER ULTRASOUND IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC VIDEO HEAD IMPULSE TEST (VHIT) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC ISCHEMIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC HEMORRHAGIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC TRANSIENT ISCHEMIC ATTACKS (TIAS) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC HOSPITAL IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC CLINICS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC HOME HEALTHCARE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC DIRECT TENDER IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 31 ASIA PACIFIC PRE OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA PACIFIC PERI OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 ASIA PACIFIC POST OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 44 JAPAN STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 45 JAPAN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 JAPAN OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 JAPAN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 JAPAN ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 JAPAN HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 JAPAN STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 JAPAN STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 JAPAN STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 53 CHINA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 54 CHINA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 CHINA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 CHINA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 CHINA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 CHINA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 CHINA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 CHINA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 CHINA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 62 INDIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 63 INDIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 64 INDIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 65 INDIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 INDIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 INDIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 INDIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 69 INDIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 INDIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 71 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 72 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 73 SOUTH KOREA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 74 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 SOUTH KOREA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 76 SOUTH KOREA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 79 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 80 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 81 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 AUSTRALIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 83 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 AUSTRALIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 85 AUSTRALIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 88 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 89 SINGAPORE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 90 SINGAPORE STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 91 SINGAPORE OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 92 SINGAPORE STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 93 SINGAPORE ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 94 SINGAPORE HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 95 SINGAPORE STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 96 SINGAPORE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 97 SINGAPORE STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 98 THAILAND STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 99 THAILAND STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 THAILAND OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 101 THAILAND STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 102 THAILAND ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 103 THAILAND HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 104 THAILAND STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 105 THAILAND STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 106 THAILAND STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 107 MALAYSIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 108 MALAYSIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 109 MALAYSIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 110 MALAYSIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 111 MALAYSIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 112 MALAYSIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 MALAYSIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 114 MALAYSIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 115 MALAYSIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 116 INDONESIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 117 INDONESIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 118 INDONESIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 INDONESIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 120 INDONESIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 121 INDONESIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 122 INDONESIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 123 INDONESIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 124 INDONESIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 125 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 126 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 127 PHILIPPINES OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 129 PHILIPPINES ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 130 PHILIPPINES HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 131 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 132 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 133 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 134 REST OF ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
Lista de Figura
FIGURE 1 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN DEMAND FOR STROKE DIAGNOSTISIS EXPECTED TO DRIVE THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 MODERATE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET
FIGURE 15 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020
FIGURE 16 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020-2028 (USD MILLION)
FIGURE 17 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, CAGR (2021-2028)
FIGURE 18 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, LIFELINE CURVE
FIGURE 19 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, 2020
FIGURE 20 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 21 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 22 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020
FIGURE 24 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 25 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 26 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, 2020
FIGURE 28 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 29 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, CAGR (2021-2028)
FIGURE 30 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 32 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 33 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 34 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, 2020
FIGURE 36 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, 2020-2028 (USD MILLION)
FIGURE 37 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, CAGR (2021-2028)
FIGURE 38 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, LIFELINE CURVE
FIGURE 39 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: SNAPSHOT (2020)
FIGURE 40 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020)
FIGURE 41 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 42 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 43 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY (2021-2028)
FIGURE 44 STROKE DIAGNOSTICS MARKET COMPANY SHARE 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
